Post by Evotec

Discover our latest ISSCR 2026 poster presentations in iPSC-based drug discovery, highlighting human-relevant approaches to Alzheimer’s disease research. 𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗻𝗴 𝗛𝘂𝗺𝗮𝗻 𝗥𝗲𝗮𝗰𝘁𝗶𝘃𝗲 𝗔𝘀𝘁𝗿𝗼𝗰𝘆𝘁𝗲𝘀 𝗶𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 A scalable iPSC-derived astrocyte platform identifies novel compounds that reverse disease-associated inflammatory states and induce neuroprotective phenotypes. 📍 𝗣𝗼𝘀𝘁𝗲𝗿 #𝗧𝟭𝟮𝟮𝟱 🗓️ Thursday, 9 July 🕑 4:00 – 5:15 PM EDT Presented by Bastian Zimmer, PhD, VP, iPSC Drug Discovery 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 𝗮𝗻𝗱 𝗥𝗲𝘃𝗲𝗿𝘀𝗶𝗻𝗴 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀-𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝗠𝗶𝗰𝗿𝗼𝗴𝗹𝗶𝗮𝗹 𝗦𝘁𝗮𝘁𝗲𝘀 An iPSC-based microglia platform combines transcriptomics and functional assays to model AD pathology and uncover compounds that restore disease-associated dysfunction. 📍 𝗣𝗼𝘀𝘁𝗲𝗿 #𝗙𝟭𝟬𝟭𝟵 🗓️ Friday, 10 July 🕑 4:00 – 5:15 PM EDT Presented by Isabelle Meyer, Research Associate, iPSC Drug Discovery Discover how human iPSC models enable deeper insights into disease biology and support the development of more predictive therapeutic strategies. Visit us during the poster sessions. 🔗 𝗣𝗼𝘀𝘁𝗲𝗿𝘀 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗳𝗼𝗿 𝗱𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘂𝗽𝗼𝗻 𝗿𝗲𝗾𝘂𝗲𝘀𝘁: https://okt.to/97wxlD #ISSCR2026 #iPSC #DrugDiscovery